James P Stewart
Overview
Explore the profile of James P Stewart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
114
Citations
3174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fabian R, Bentley E, Kirby A, Sharma P, Stewart J, Kipar A
Vet Pathol
. 2025 Feb;
:3009858251315115.
PMID: 39931823
Malignant catarrhal fever (MCF) is an often fatal, sporadic gammaherpesvirus-induced disease of ruminants with global relevance. Ovine gammaherpesvirus-2 (OvHV-2), with sheep as its reservoir host, is a major cause of...
2.
Hesius E, Stevens W, Stewart J, Kroeze L, Spek E, Issa D, et al.
J Clin Pathol
. 2025 Jan;
PMID: 39890445
Aims: Follicular lymphoma (FL) is characterised by significant heterogeneity in both the clinical trajectories and the molecular profiles. This study aimed to investigate clonal dynamics in FL by analysing mutation...
3.
Mega D, Sharma P, Kipar A, Hetzel U, Bramwell C, Merritt A, et al.
Viruses
. 2025 Jan;
16(12.
PMID: 39772226
Seaweed-derived compounds are a renewable resource utilised in the manufacturing and food industry. This study focuses on an enriched seaweed extract (ESE) isolated from The ESE was screened for antiviral...
4.
Neary M, Gallardo-Toledo E, Sharp J, Herriott J, Kijak E, Bramwell C, et al.
Viruses
. 2025 Jan;
16(12.
PMID: 39772148
Favipiravir (FVP) and remdesivir (RDV) have demonstrable antiviral activity against SARS-CoV-2. Here, the efficacy of FVP, RDV, and FVP with RDV (FVP + RDV) in combination was assessed in Syrian...
5.
Fabian R, Rosato G, Stewart J, Kipar A
Viruses
. 2024 Nov;
16(11).
PMID: 39599845
Bovine gammaherpesvirus 6 (BoHV-6) is endemic in cattle in Europe, with a high prevalence. There is evidence that the virus is a commensal and not associated with disease processes. For...
6.
Mostafa A, Naguib M, Nogales A, Barre R, Stewart J, Garcia-Sastre A, et al.
mBio
. 2024 Nov;
15(12):e0254224.
PMID: 39535188
Since the emergence of highly pathogenic avian influenza virus (HPAIV) H5N1 of clade 2.3.4.4b as a novel reassortant virus from subtype H5N8, the virus has led to a massive number...
7.
Dunai C, Hetherington C, Boardman S, Clark J, Sharma P, Subramaniam K, et al.
Front Immunol
. 2024 Oct;
15:1440324.
PMID: 39474424
Neurological complications, including encephalopathy and stroke, occur in a significant proportion of COVID-19 cases but viral protein is seldom detected in the brain parenchyma. To model this situation, we developed...
8.
Tatham L, Kipar A, Sharp J, Kijak E, Herriott J, Neary M, et al.
Microbiol Spectr
. 2024 Jul;
12(8):e0391623.
PMID: 39012120
With some exceptions, global policymakers have recommended against the use of existing monoclonal antibodies in COVID-19 due to loss of neutralization of newer variants. The purpose of this study was...
9.
Clark J, Penrice-Randal R, Sharma P, Dong X, Pennington S, Marriott A, et al.
Viruses
. 2024 Jun;
16(6).
PMID: 38932155
COVID-19 is a spectrum of clinical symptoms in humans caused by infection with SARS-CoV-2. The coalescence of SARS-CoV-2 with seasonal respiratory viruses, particularly influenza viruses, is a global health concern....
10.
Cornish K, Huo J, Jones L, Sharma P, Thrush J, Abdelkarim S, et al.
Open Biol
. 2024 Jun;
14(6):230252.
PMID: 38835241
The Omicron strains of SARS-CoV-2 pose a significant challenge to the development of effective antibody-based treatments as immune evasion has compromised most available immune therapeutics. Therefore, in the 'arms race'...